Compare BridgeBio Pharma Inc (BBIO) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Riot Platforms Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Riot Platforms Inc trades at $20.91 (market cap $7.59B). The key difference: BridgeBio Pharma Inc is far larger — about 2.2× Riot Platforms Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | RIOT | |
|---|---|---|
Market Cap | $16.36B | $7.59B |
Sector | Health | Technology |
52-Week High | $90.17 | $28.67 |
52-Week Low | $47.29 | $11.33 |
Enterprise Value | $18.14B | $8.00B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
